Cognate interaction of chemokine receptor CCR7 on lymphocytes with its ligands CCL19 and CCL21 expressed on high endothelial venules (HEVs) is essential for effective migration of T and B cells across HEVs into secondary lymphoid organs. Plt mice, which lack expression of CCL19 and CCL21-ser, both ligands for CCR7 on HEVs, as well as CCR7-deficient mice, have a defective cell migration and reduced homing of lymphocytes. FTY720, a novel immunosuppressant, causes a reduction of lymphocytes in peripheral blood and tissues and their sequestration into lymphoid tissues. In this study we demonstrate that FTY720 rescues the homing defect in both CCR7−/− mice and plt mice. After FTY720 treatment, the number of CD4+ and CD8+ T cells as well as B cells in peripheral blood is reduced while pertussis toxin–sensitive homing into peripheral lymph nodes, mesenteric lymph node, and Peyer's patches is increased. Immunohistology demonstrates that FTY720 enables these cells to enter lymphoid tissue through HEVs. Thus, our data suggest an alternative G-αi-dependent, CCR7-CCL19/CCL21-independent mechanism for lymphocyte homing through HEVs which is strongly augmented in the presence of FTY720.
Skip Nav Destination
Article navigation
17 December 2001
Article Contents
Brief Definitive Report|
December 17 2001
CC Chemokine Receptor 7–dependent and –independent Pathways for Lymphocyte Homing : Modulation by FTY720
Golo Henning,
Golo Henning
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Search for other works by this author on:
Lars Ohl,
Lars Ohl
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Search for other works by this author on:
Tobias Junt,
Tobias Junt
2Institute for Experimental Immunology, Department of Pathology, University Hospital, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Phillip Reiterer,
Phillip Reiterer
3Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany
Search for other works by this author on:
Volker Brinkmann,
Volker Brinkmann
4Novartis Pharma AG, CH-4002 Basel, Switzerland
Search for other works by this author on:
Hideki Nakano,
Hideki Nakano
5Department of Immunology, Toho University School of Medicine, Ota-Ku, Tokyo 143-8540, Japan
Search for other works by this author on:
Werner Hohenberger,
Werner Hohenberger
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Search for other works by this author on:
Martin Lipp,
Martin Lipp
3Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany
Search for other works by this author on:
Reinhold Förster
Reinhold Förster
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Search for other works by this author on:
Golo Henning
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Lars Ohl
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Tobias Junt
2Institute for Experimental Immunology, Department of Pathology, University Hospital, CH-8091 Zürich, Switzerland
Phillip Reiterer
3Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany
Volker Brinkmann
4Novartis Pharma AG, CH-4002 Basel, Switzerland
Hideki Nakano
5Department of Immunology, Toho University School of Medicine, Ota-Ku, Tokyo 143-8540, Japan
Werner Hohenberger
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Martin Lipp
3Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany
Reinhold Förster
1Section of Experimental Surgery and Immunology, University Clinic for Surgery and Nikolaus-Fiebiger-Zentrum, 91054 Erlangen, Germany
Address correspondence to Prof. Dr. Reinhold Förster at his present address, Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany. Phone: 49-511-532-0; E-mail: [email protected]
G. Henning and L. Ohl contributed equally to this work.
Received:
September 24 2001
Revision Received:
October 30 2001
Accepted:
November 12 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2001
J Exp Med (2001) 194 (12): 1875–1881.
Article history
Received:
September 24 2001
Revision Received:
October 30 2001
Accepted:
November 12 2001
Citation
Golo Henning, Lars Ohl, Tobias Junt, Phillip Reiterer, Volker Brinkmann, Hideki Nakano, Werner Hohenberger, Martin Lipp, Reinhold Förster; CC Chemokine Receptor 7–dependent and –independent Pathways for Lymphocyte Homing : Modulation by FTY720 . J Exp Med 17 December 2001; 194 (12): 1875–1881. doi: https://doi.org/10.1084/jem.194.12.1875
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement